Health In TechHIT
Recorded

Health In Tech 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration1 hr 8 minParticipants8

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good afternoon, ladies and gentlemen, and welcome to Health In Tech's third quarter 2026 earnings conference call. All participants are currently in listen-only mode. After the prepared remarks, we will open the call for questions. As a reminder, today's conference call is being recorded. If you have any objections, you may disconnect at this time. I will now turn the call over to Lori Babcock, Chief of Staff.

Lori BabcockChief of Staff

Lori, please go ahead. Thank you, operator, and good afternoon, everyone.

Lori BabcockChief of Staff

Welcome to Health In Tech's third quarter 2026 earnings call. Joining us today are Tim Johnson, our Founder and Executive Chairman, Sanjay Shrestha, our Chief Executive Officer, and Julia Qian, our Chief Financial Officer. The details of our results are in today's earnings release and our related Form 10-Q to be filed with the SEC. Both will be available on our investor relations website at healthintech.investorroom.com, where a replay of this call will also be posted. Before we continue, please note that today's discussion includes forward-looking statements under the safe harbor provision of the federal securities laws. These statements reflect our current expectations and involve risks and uncertainties that could cause actual results to differ materially. Please refer to our earnings release and SEC filings for the applicable risk factors. We undertake no obligation to update these statements except as required by law.

Lori BabcockChief of Staff

We may also discuss non-GAAP measures, including adjusted EBITDA. The relevant definitions and reconciliations to GAAP measures will be provided in our earnings release. With that, I turn the call over to Tim.

Tim JohnsonFounder and Executive Chairman

Thanks, Lori. Before we discuss our business performance and outlook, I would like to take a moment to highlight an important leadership transition at Health In Tech and formally introduce Sanjay Shrestha as our new Chief Executive Officer. Since founding Health In Tech, my vision has been to transform the health insurance industry through technology, innovation, and vertical integration. Over the years, we have built a differentiated technology platform designed to simplify complex processes, improve efficiency, and create greater transparency across the health insurance marketplace. As we look towards the next chapter of our growth, I believe the company has reached an important stage in its evolution. While innovation and technology development will always remain central to our business, our next phase requires an even greater emphasis on commercial execution, operational scalability, business expansion, and the ability to capitalize on strategic growth opportunities.

Tim JohnsonFounder and Executive Chairman

That is the rationale behind our leadership transition. By separating the roles of Executive Chairman and Chief Executive Officer, we are creating a leadership structure that allows us to dedicate greater focus and resources to two equally important priorities: continuing to innovate and build for the future while accelerating execution and scaling the business we have established. My role as Executive Chairman, I will remain actively involved in shaping the company's long-term strategy, advancing technology innovation, and guiding product development. I will also continue to leverage my industry experience and relationships to identify emerging opportunities and help position Health In Tech for long-term success. Sanjay, as CEO, will lead our day-to-day operations and be responsible for driving commercial execution, strengthening our organizational capabilities, scaling our existing business, and improving overall operating performance.

Tim JohnsonFounder and Executive Chairman

Importantly, Sanjay will also lead our efforts to identify and evaluate potential strategic acquisitions, partnerships, and other business expansion opportunities. We believe that combining organic growth with disciplined strategic acquisitions could provide additional avenues to expand our capabilities, strengthen our market position, and create meaningful long-term value for our shareholders. Sanjay brings extensive experience in public company leadership, capital markets, corporate strategy, and business development. Having previously served on our board and worked closely with our leadership team, he already has a strong understanding of our business, our technology, and the opportunities ahead. I believe his experience and capabilities complement my own, and that together we can strengthen Health In Tech's ability to translate our innovation and strategic vision into sustainable business growth. I also want to emphasize that my transition to Executive Chairman is not a step away from Health In Tech.

Tim JohnsonFounder and Executive Chairman

My commitment to the company, our employees, our partners, and shareholders remains as strong as ever. This transition allows me to focus more on my time and energy on long-term strategy, innovation, and the next generation of products, opportunities, while Sanjay provides dedicated leadership to execute and scale our business. Ultimately, this is about building a stronger Health In Tech, one with leadership capacity to innovate, execute, expand, and pursue opportunities that enhance long-term shareholder value. I'm excited about this next chapter and confident in the leadership team we are building. With that, it is my pleasure to welcome Sanjay Shrestha as Chief Executive Officer of Health In Tech. Sanjay, I turn it over to you.

Sanjay ShresthaCEO

Thank you, Tim, and good afternoon, everyone. It is a pleasure to join you today for my first earnings call as Chief Executive Officer of Health In Tech. I would like to use this opportunity to share my perspective on the business, the opportunities ahead of us, and importantly, the priorities I believe will be critical to translating those opportunities into sustainable growth and long-term shareholder value. Having served on Health In Tech's board and subsequently as a strategic advisor, I have had the opportunity to develop a strong understanding of the company's technology, business model- industry relationship, and long-term potential. Stepping into the CEO role, however, provides an even closer perspective on our day-to-day operations, commercial execution, and opportunity to strengthen our performance. And one thing that has become very clear to me, we believe Health In Tech has built a strong foundation.

Sanjay ShresthaCEO

Our key focus and strategic priority now is to translate that foundation into scalable commercial growth and stronger financial performance. As it relates to 2026, this really is a year of investment and building for the future. Let me begin by putting 2026 into perspective. Again, as I said, this has been an important year of investment and capability building for Health In Tech. We have invested in expanding our sales and distribution network, strengthening relationship with brokers, carrier, managing general underwriter, MGUs, and strategic partners, and continuing to develop the underlying technology that supports our marketplace. At the same time, we have advanced several significant initiatives, including recently launched HitRix, HITChain, and our Three-Year Rate Stabilization Program. Each of these initiatives address substantial market opportunities in the area of the healthcare insurance ecosystem, where we believe there has been relatively limited technological innovation.

Sanjay ShresthaCEO

Our objective has not been solely to maximize near-term revenue. We have been building the technology, distribution relationship, financial infrastructure, and product capabilities that we believe can support a much larger and more diversified business over time. That said, we recognize that certain initiatives, frankly, have taken longer than originally anticipated. Product commercialization has required more time. Bringing additional carrier capacity online has taken longer than expected, and coordinating the multiple participants required to launch some of our newer product has introduced additional complexity. As a result, the financial contribution from several important initiatives has been pushed beyond our original expectations. I want to be very clear. We are not satisfied with our current revenue performance. Investment is necessary, but investment alone does not create value for all stakeholders. Ultimately, those investment needs to be translated into customer adoption, transaction volume, revenue growth, and improved financial performance.

Sanjay ShresthaCEO

This is a standard by which we intend to measure our progress going forward. Throughout my career, I have been fortunate enough to have worked with businesses where the market opportunity was substantial, but realizing that opportunity required aligning commercial execution, operational discipline, organizational capabilities, and capital allocation. I have substantial operating experience scaling new product from incubation to meaningful commercial scale, building first-of-a-kind large-scale process plant, and large-scale renewable assets on a global basis. I share that experience not to suggest that Health In Tech will follow the same trajectory or the timeline, but because I've seen firsthand what becomes possible when a compelling business opportunity is supported by the right strategy, people, execution capabilities, and disciplined capital allocation.

Sanjay ShresthaCEO

Based on that, my first priority is to be laser-focused on re-accelerating our core business to improve outcome for all stakeholders, which includes our carrier partners, MGUs, brokers, third-party administrator, and more importantly, our clients who are looking for attractive and economical health coverage. I will discuss in more detail our newer initiative that we believe will offer substantial future opportunity. I believe it is important to reiterate that we have an existing core business with meaningful commercial activity and a growing network of distribution partner. We're focused on execution and re-accelerating this business as we look into 2027. Our existing platform and MGU-related solutions support the self-funded medical stop-loss market, including employer across small and large group segments. These offerings provide an established commercial foundation upon which we believe we can expand.

Sanjay ShresthaCEO

Just to put some numbers in context, as of October 30, 2026, our platform had approximately $150 million in potential annualized revenue associated with quoting activity for policy with anticipated effective dates in November of 2026, December 2026, and January 2027. Approximately 70% of that pipeline was associated with January 1, 2027 anticipated policy effective date, and we expect quoting activity for that period to continue developing. I want to emphasize that this pipeline represents potential business opportunities, not contracted or recognized revenue. Actual conversion will depend on underwriting, pricing, broker and employer decisions, carrier capacity, and successful policy placement. For me, this creates a clear and immediate execution priority. We need to focus on converting qualified opportunity into bound policies and ultimately recognized revenue. That means working more proactively with brokers, distribution partners, carriers, and MGUs to identify and resolve obstacles that may delay or prevent conversion.

Sanjay ShresthaCEO

We're placing greater emphasis on active pipeline management, stronger follow-through, improved coordination, and accountability throughout the quoting and placement process. Rather than measuring success simply by the volume of opportunities entering the platform, we need to focus on how effectively those opportunities progress through the commercial process. This includes tracking conversion rates, identifying bottlenecks, strengthening partner engagement, and improving the overall efficiency of underwriting and policy placement. We also see opportunity to better integrate the products and capabilities within our broader ecosystem. Our existing eDIYBS and SMR platform, MGU-related solution, HitRix, and Three-Year Rate Stabilization Program address complementary needs across the self-funded insurance marketplace. Together, they create opportunities to serve a broader range of employers, strengthen partner relationship, and potentially capture additional value throughout the insurance distribution and underwriting process.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day